Insider Transactions

What SOLENO THERAPEUTICS INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	6
Total trades	0	37

Shares traded

	3 months	12 months
Acquired	0	279,757
Disposed	0	1,019,318
Net activity	+0	−739,561

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Pauls Matthew	Director	May 18	Disposition to Issuer · D	−10,491	—	—	0
Anish Bhatnagar	CHIEF EXECUTIVE OFFICER	May 18	Disposition to Issuer · D	−583,656	—	—	0
Hahn Mark W	Director	May 18	Disposition to Issuer · D	−10,046	—	—	0
Hirano Patricia C	SEE REMARKS	May 18	Disposition to Issuer · D	−22,702	—	—	0
Norrett Kevin	Chief Business Officer	May 18	Disposition to Issuer · D	−17,786	—	—	0
Yen Kristen	SEE REMARKS	May 18	Disposition to Issuer · D	−37,639	—	—	0
Manning Meredith	Chief Commercial Officer	May 18	Disposition to Issuer · D	−64,507	—	—	0
Volck Birgitte	Director	May 18	Disposition to Issuer · D	−17,536	—	—	0
Fulk Jennifer	CHIEF FINANCIAL OFFICER	May 18	Disposition to Issuer · D	−39,200	—	—	0
Huang Michael F.	Sr. VP of Clinical Development	May 18	Disposition to Issuer · D	−39,823	—	—	0
Bir Dawn Carter	Director	May 18	Disposition to Issuer · D	−16,991	—	—	0
Sinclair Andrew	Director	May 18	Disposition to Issuer · D	−10,491	—	—	0
Joshi Manher	Chief Development Officer	May 18	Disposition to Issuer · D	−20,171	—	—	0
Manning Meredith	Chief Commercial Officer	Mar 27	Open-market sale · S	−558	$31.72	−$17.7K	64,507
Manning Meredith	Chief Commercial Officer	Mar 27	Open-market sale · S	−2,100	$31.04	−$65.2K	65,065
Manning Meredith	Chief Commercial Officer	Mar 27	Open-market sale · S	−4,864	$30.04	−$146K	67,165
Huang Michael F.	Sr. VP of Clinical Development	Mar 27	Open-market sale · S	−488	$31.72	−$15.5K	39,823
Huang Michael F.	Sr. VP of Clinical Development	Mar 27	Open-market sale · S	−1,838	$31.04	−$57K	40,311
Huang Michael F.	Sr. VP of Clinical Development	Mar 27	Open-market sale · S	−4,256	$30.04	−$128K	42,149
Fulk Jennifer	CHIEF FINANCIAL OFFICER	Mar 02	Grant / award · A	+39,200	—	—	39,200

Page 1 of 38 · showing the 20 most recent Sign up free to view all 741 transactions and filter by insider →

Comments